LRRTM3: A Promising Drug Target and Biomarker (G347731)

Target Name: LRRTM3

NCBI ID: G347731

LRRTM3

LRRTM3: A Promising Drug Target and Biomarker

The development of new drug targets and biomarkers is a critical aspect of modern medicine. These targets and biomarkers can help identify and treat diseases, improve patient outcomes, and reduce healthcare costs. One such target that has gained significant attention in recent years is the protein known as LRRTM3 (NOAH10). In this article, we will explore LRRTM3 and its potential as a drug target and biomarker.

The LRRTM3 Protein

LRRT

Protein Name: Leucine Rich Repeat Transmembrane Neuronal 3

Functions: Exhibits a limited synaptogenic activity in vitro, restricted to excitatory presynaptic differentiation (By similarity). May play a role in the development and maintenance of the vertebrate nervous system

The "LRRTM3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRTM3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets